In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Conditions:   Pheochromocytoma;   Paraganglioma Intervention:   Drug: [18F]FluorThanatrace ([18F]FTT) Sponsor:   Heather Wachtel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials